Megakaryocyte Study for Sickle Cell Disease
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks at a certain type of blood cell (megakaryocytes) in people with sickle cell disease. It aims to learn more about the disease and is only for patients followed at the Guadeloupe sickle cell center who are in a stable phase (no recent crisis or transfusion).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have SS or SC sickle cell disease (confirmed by a specific test).
- You are at least 18 years old.
- You have not had a sickle cell complication in the last month or a blood transfusion in the last 3 months.
- You get your sickle cell care at the University Hospital of Guadeloupe.
- You are willing to sign a consent form and have French national health insurance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at the cells that help make platelets (megakaryocytes) in people with sickle cell disease. By comparing these cells when you are feeling well and during a pain crisis or chest syndrome, researchers hope to learn more about the condition and find better treatments.
This study collects kidney tissue samples from people with sickle cell disease and healthy volunteers to better understand how sickle cell affects the kidneys. If you have sickle cell disease or a related blood disorder, you may help researchers find new ways to protect kidney function.
This study looks at how different types of sickle cell disease (SS, S/beta0, S/C) are linked to blood clotting and disease severity. It may help doctors better understand the condition and how to treat it.
This study looks at how severe dengue fever affects people with sickle cell disease. It aims to understand why some people with sickle cell get very sick from dengue and how their cells react.
This study looks at how major organs like the brain, kidneys, heart, and liver are affected in adults with sickle cell disease, whether they've had a bone marrow transplant or gene therapy, or are continuing regular treatment. You'll get detailed tests that can help doctors understand the disease better, which may lead to improved care.
This trial tests a “biochip” device using samples from people with sickle cell disease. If it works, it may help doctors study sickle cell biology more accurately using patient samples.
Hear when a new Sickle Cell Disease (SCD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.